Stoke Therapeutics

Home » Stoke Therapeutics

IPO

Stoke Therapeutics

Biotechnology

We are pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.

Symbol

STOK

Price Range
$14.00 - $16.00

Final Shares
6,700,000

Anticipated Date
June 20, 2019

Underwriters
J.P. MORGAN SECURITIES LLC,CREDIT SUISSE SECURITIES (USA) LLC

This offering is no longer available

To view the prospectus for Stoke Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253